UNSPSC 51391606: Prenylamine

This classification denotes an adrenergic agent, calcium channel blocker, and vasodilator agent with the molecular formula C24H27N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K2OH82Z000, chemically known as 1-phenyl-2-(1,1-diphenylpropyl-3-amino)propane but generally known as prenylamine, which bears US NIH Compound Identifier 9801. European Medicines Agency schedules Prenylamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10030MIG.

UNSPSC 51391606 Prenylamine, a Commodity code, nominally addresses a specific pharmaceutical compound, but the recent state and local opportunity record shows material divergence from this scope. Seminole County, Florida's IFB 60459723LAS solicits naloxone and drug deactivation systems rather than prenylamine itself — a mismatch that reflects how state and local agencies sometimes tag procurements with codes that do not align precisely with the products being purchased. The actual work under this code tag involves acquiring emergency-response pharmaceuticals and associated containment or neutralization systems to support public health initiatives, with quarterly deliveries, electronic bidding, and standard compliance requirements including drug-free workplace certification and E-Verify. Issuing bodies appear limited to county-level health and emergency-response departments based on the available record.

Seminole County represents the only recent documented activity under this code. The IFB released on June 30, 2026, with response due July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building in Sanford, Florida, with an initial two-year term and one-year renewal option. The procurement imposes standard contracting requirements — workers' compensation and commercial general liability insurance, potential FEMA funding compliance including Clean Air Act and Federal Water Pollution Control Act adherence, and a three-month probationary termination clause. Because recent activity is limited to this single Florida opportunity and the code's nominal pharmaceutical scope does not reflect the actual products being sourced, the code shows little actionable recent state and local procurement momentum.